GoodRx is a medical utility app for iOS that provides prescription price comparisons, digital coupons, and telehealth consultations.
Product velocity
Active
Daily rank 🇺🇸
#8
▲2Medical · free
Sentiment
4.8
694k reviews
Nemesis
Fragmented field
The App DNA
What makes this app unique?
Users hire GoodRx to bypass high out-of-pocket drug costs and access virtual care without needing traditional insurance, solving the immediate need for affordable medication access.
For Individuals seeking to reduce out-of-pocket prescription costs and those requiring accessible, virtual medical consultations without traditional insurance.
Key features
Aggregates and compares drug prices across 70,000+ U.S. pharmacies
Provides free, scannable discount codes for use at pharmacy checkout
Subscription tier offering exclusive pricing, rewards, and additional benefits
How much does it cost?
Freemium model anchored by free utility for price discovery, with a subscription layer for deeper discounts and telehealth access.
Velocity
Active developmentopaqueperformanceUX improvementsShow more...
GoodRx maintains an active development cadence, shipping 5 releases over the last 37 days, averaging approximately 0.95 releases per week. Despite this high frequency, the publisher consistently uses identical, opaque release notes that provide no insight into specific feature additions or technical changes. This pattern is consistent with the deployment of server-side feature flags or A/B testing rather than traditional App Store-driven feature releases. The development trend remains stable, focusing on continuous, incremental updates.
Who built it?
User Sentiment
What do users think recently?
Fresh user feedback skews thrilled. Users appreciate significant out-of-pocket prescription cost reductions provide essential financial relief for uninsured or underinsured users.
How are ratings & reviews evolving?
What users say, by theme
- Significant out-of-pocket prescription cost reductions provide essential financial relief for uninsured or underinsured users
- Authentication errors following the latest update prevent users from accessing their accounts within the mobile application
49 of 49 recent reviews analyzed · high confidence · Thrilled overall
Read the full review analysisCompetition
Competitive landscape for GoodRx: Prescription Savings
How's the Medical market?
GoodRx holds the #9 Free position in the US Medical chart. The gap between its broad coupon utility and the specialized PBM-integrated apps signals a need to defend the core coupon experience against leaner rivals.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for GoodRx: Prescription Savings
Where is it heading?
The prescription savings market is consolidating, with PBM-integrated apps increasingly offering personalized pricing that out-competes generic coupons. GoodRx must pivot from a coupon-first utility to a personalized health management platform to retain users, or risk being commoditized by pharmacy-owned apps.
- Authentication regressions in the latest update prevent account access, which erodes the daily habit and compounds rating drag.
- High-intent pharmacy traffic remains strong, providing a steady affiliate revenue stream that funds the telehealth expansion.
The SWOT
- 70,000+ pharmacy network creates a distribution barrier
- Gold membership rewards create recurring revenue layer
- Untapped B2B distribution via employer health benefits
- Expansion of adherence tools into chronic management
Next best moves
Rebuild authentication service because login failures are the top-reported complaint → stabilize daily active usage
The counter-intuitive read
The primary threat is not a better telehealth competitor…
Read the full takeFeature gaps
Direct-to-door prescription delivery (available in NimbleRx but absent here) +1
Since the last report: GoodRx transitioned to a freemium pricing model while experiencing a decline in user sentiment due to new authentication regressions.
Bottom line
GoodRx holds its category lead through massive pharmacy network coverage but risks losing users to leaner rivals due to recent login regressions, so revenue growth hinges on stabilizing the core coupon access.
Unlock 2 critical frictions, 2 market threats and the analyst’s take.
Access the full report for freeReport last updated